We are honored to announce MedNewsWeek participation at #ASCO24! Thank you ASCO Journal of Clinical Oncology for the possibility to share our impact on enhancing equity and inclusivity in hematology-oncology education. We're committed to making even more significant contributions in the future!

Pancreatic cancer research is crucial as it’s predicted to become the second deadliest tumor. Our review in Cancers MDPI, inspired by Mike Pishvaian  of Johns Hopkins University, discusses the promise of personalized medicine in improving outcomes for this complex and fascinating disease.